Warsaw Genomics, a start-up company of the UW, has developed a cancer-risk assessment method which predicts the risk of getting cancer. The start-up has been recognised by Central European Startup Awards as the best biotech start-up in Poland.
Some people have inherited gene faults that increase their risk of developing particular types of cancer. An interdisciplinary research team at the University of Warsaw, Warsaw Genomics, led by Prof. Krystian Jażdżewski, has developed a cancer-risk assessment method which predicts the risk of getting cancer. The method is based on clinical data provided by the patients and genomic data obtained by next generation sequencing of all the genes associated with familiar cancers.
– Our goal is to identify all of the people with a high risk of cancer in the Polish population of 38 million. It is estimated that there are at least 200 000 women with a high risk of breast cancer. We target at finding them all, with the goal of providing a personalised prophylactic programme – says Prof. Krystian Jażdżewski.
The university start-up has been recognised by the Central European Startup Awards as the best start-up in Poland. On 23rd November, CESA will announce the winners of Central and Eastern Europe region. 10 countries take part in the competition: Austria, Bulgaria, Croatia, Czech Republic, Poland, Romania, Serbia, Slovakia, Slovenia and Hungary.